英文字典中文字典51ZiDian.com

中文字典辞典英文字典 a b c d e f g h i j k l m n o p q r s t u v w x y z

harborage

XDict

n. 停泊处;避难所

PyDict

停泊处;避难所

WordNet (r) 3.0 (2006) (WordNet)

harborage
n 1: (nautical) a place of refuge (as for a ship) [synonym:
{harborage}, {harbourage}]

The Collaborative International Dictionary of English v.0.48 (gcide)

Harborage \Har"bor*age\ (-[asl]j), n.
Shelter; entertainment.[R.]
[1913 Webster]

Where can I get me harborage for the night? --Tennyson.
[1913 Webster]

请选择你想看的字典辞典：

单词	字典	翻译
harborage	查看　harborage　在百度字典中的解释	百度英翻中〔查看〕
harborage	查看　harborage　在Google字典中的解释	Google英翻中〔查看〕
harborage	查看　harborage　在Yahoo字典中的解释	Yahoo英翻中〔查看〕

安装中文字典英文字典查询工具!

中文字典英文字典工具:

选择颜色:

<style type="text/css">#word104_1 br {display:none;}</style>
<form id="word104_1" method="post" action="http://es.goldgoldprice.com/index.php" target="_blank">
<div style="width: 140px;border:1px solid #000;background-color:#ffffff;padding: 0px 0px;margin: 0px 0px;align:center;text-align:center;overflow:hidden;"><div id="xcolor1_1" style="font-size:12px;color:#183a00;line-height:16px;font-family: arial; font-weight:bold;background:#94abf0;padding: 3px 1px;text-align:center;"><a href="http://es.goldgoldprice.com/" alt="英文字典中文字典" title="英文字典中文字典" id="word_name104_1" style="color:#000000;font-size:14px;text-decoration:none;line-height:16px;font-family: arial;" >英文字典中文字典</a></div><table width=100% style='align:center;text-align:left;font-size:12px;background-color:#ffffff;color:#333333;'>
<tr><td style="text-align:center;border:0"><input type=hidden name="word104_hi" value="1">输入中英文单字</td></tr><tr><td style="text-align:center;border:0"><input type="text" name="word104_input" value="" size=10 style="background-color:#ffffff;color:#000;text-decoration:none;font-family: arial;rial;border:1px solid #999;padding:1px!important;"></td></tr><tr style='line-height: 26px;'><td style="text-align:center;border:0"><input type=submit style="background-color:#ccc;color:#000;border:0 none;cursor:pointer;" value="查询字典"></td></tr></table></div>
</form>

英文字典中文字典相关资料:

Acelot
* Acelot is pursuing targets that have demonstrated potential applicability in a range of neurodegenerative diseases, including TDP-43 positive fronto-temporal dementia, Alzheimer's disease (AD), inclusion body myositis, multiple system atrophy, and dementia with Lewy bodies
Katie Planey — Acelot
Chief Executive Officer Katie Planey, PhD, MBA, joined Acelot as a member of the Board of Directors in 2021 and as Chief Executive Officer in 2022 Katie has extensive experience in the field of biotechnology and business strategy, with a special ability to define key strategic initiatives in uncharted and complex scientific and engineering fields
Marcie Glicksman — Acelot
Marcie Glicksman, PhD, joined Acelot as the Acting Chief Scientific Officer in 2024 She is an accomplished biotechnology executive with over 30 years of experience dedicated to developing innovative therapeutics, mainly for the nervous system and other complex therapeutics areas
Lewis Whitehead — Acelot
Lewis Whitehead, PhD, joined Acelot in 2023 as Vice President of Research, Computational Discovery Lewis is an experienced and accomplished computational medical chemist with a 25 year history in the pharmaceuticals industry
Acelot will be presenting at the 13th Annual Alzheimer’s Parkinson’s . . .
Showcasing Preclinical Promise of Targeting TDP-43 in Alzheimer’s Disease 2:00 pm Conference Day Two - Track Two Details: Reviewing why targeting TDP-43 has historically been difficult Outlining the mechanisms of the small molecule to directly target TDP-43 Character
Shruti Arya — Acelot
Shruti Arya, PhD Senior Scientist I Shruti Arya, PhD, joined Acelot in 2023 as a Senior Scientist Dr Arya brings extensive experience to the development of diverse therapies for neurodegenerative diseases With a background in chemistry and advanced training in biophysics, she offers a unique, multidisciplinary approach to drug discovery at
Vidhu Mathur — Acelot
Vidhu Mathur, PhD, joined Acelot in 2022 She is currently Sr Director, R D Dr Mathur is a seasoned drug developer and scientist with over 15 years of experience specializing in neurodegeneration, inflammation, and autoimmunity
Andrew Perlman — Acelot
Dr Perlman serves as an advisor to Acelot He has been a long-time leader in the biotechnology field, and currently serves as Co-Founder and Head of Pre-Clinical Science at X-37, an AI-enabled drug discovery company, as well as Co-Founder and Chief Medical Officer at Velocity Pharmaceutical Development
Ambuj Singh — Acelot
Dr Singh is a Founder and Board Member for Acelot He is a Distinguished Professor of Computer Science, Biomolecular Science and Engineering at the University of California, Santa Barbara, where he teaches graduate and undergraduate courses

中文字典-英文字典 2005-2009